Page last updated: 2024-10-25

deferiprone and Lung Neoplasms

deferiprone has been researched along with Lung Neoplasms in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Mimosine treatment resulted in cell cycle blocks at the G(1)/S-phase border and in S phase."1.31Radiation sensitization of mammalian cells by metal chelators. ( Cook, J, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, ZL1
Wang, NN1
Ma, QL1
Chen, Y1
Yao, L1
Zhang, L1
Li, QS1
Shi, MH1
Wang, HF1
Ying, Z1
Cook, J1

Other Studies

2 other studies available for deferiprone and Lung Neoplasms

ArticleYear
Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells.
    Acta pharmacologica Sinica, 2020, Volume: 41, Issue:1

    Topics: A549 Cells; Cell Death; Deferiprone; Genes, Tumor Suppressor; Germ-Line Mutation; Humans; Iron Chela

2020
Radiation sensitization of mammalian cells by metal chelators.
    Radiation research, 2001, Volume: 155, Issue:2

    Topics: Animals; Cell Cycle; Chelating Agents; Colony-Forming Units Assay; Cricetinae; Cricetulus; Deferipro

2001